This paper investigates the intersection of the HIV/AIDS epidemic with the structural limitations and coverage gaps within the American health insurance system. The author, Jill Eden, writing under the auspices of the Office of Technology Assessment (OTA), synthesizes data regarding the financial burden of AIDS treatment and the subsequent strain on private and public insurance models. The work argues that the rapid escalation of medical costs associated with the disease necessitates a reevaluation of risk assessment and coverage mandates.

Experts recognize this document as a significant historical record of the policy challenges faced during the early years of the AIDS crisis. Researchers frequently cite this paper for its detailed examination of the economic pressures that shaped subsequent health insurance regulations in the United States.